KETOROLAC-BAXTER ketorolac trometamol 10 mg/1 mL solution for injection ampoule Australia - inglés - Department of Health (Therapeutic Goods Administration)

ketorolac-baxter ketorolac trometamol 10 mg/1 ml solution for injection ampoule

baxter healthcare pty ltd - ketorolac trometamol, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium chloride; ethanol; nitrogen; water for injections; hydrochloric acid; sodium hydroxide - ketorolac-baxter is indicated for the short-term management of moderately severe, acute pain following surgical procedures. the total duration of ketorolac use should not exceed five days.,it is recommended that ketorolac parenteral be used in the immediate post-operative period. patients can then be converted to the oral formulation (dependent on their analgesic needs), as outlined in section 4.2 dose and method of administration (refer to "conversion from intramuscular to oral therapy"). the total period of treatment utilising the oral and/or intramuscular route of administration is not to exceed five days.,general,ketorolac-baxter is not recommended for use as an obstetrical pre-operative medication or for obstetrical analgesia because it has not been adequately studied for use in these circumstances and because the known effects of drugs that inhibit prostaglandin biosynthesis on uterine contraction and foetal circulation.,there is no satisfactory evidence for the use of ketorolac-baxter in acute exacerbations of chronic painful inflammatory conditions (e.g. rheumatoid or osteoarthritis).

MIDAZOLAM ACCORD midazolam (as hydrochloride) 15 mg/3 mL solution for injection ampoules Australia - inglés - Department of Health (Therapeutic Goods Administration)

midazolam accord midazolam (as hydrochloride) 15 mg/3 ml solution for injection ampoules

accord healthcare pty ltd - midazolam, quantity: 15 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections; sodium chloride; hydrochloric acid - ? iv as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic;,? iv for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time.,? iv for sedation in intensive care units; intermittent administration or continuous infusion.,? im for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

MIDAZOLAM ACCORD midazolam (as hydrochloride) 5 mg/1 mL solution for injection ampoules Australia - inglés - Department of Health (Therapeutic Goods Administration)

midazolam accord midazolam (as hydrochloride) 5 mg/1 ml solution for injection ampoules

accord healthcare pty ltd - midazolam, quantity: 5 mg - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide; sodium chloride - ? iv as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic;,? iv for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time.,? iv for sedation in intensive care units; intermittent administration or continuous infusion.,? im for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

MIDAZOLAM ACCORD midazolam (as hydrochloride) 5 mg/ 5 mL solution for injection ampoules Australia - inglés - Department of Health (Therapeutic Goods Administration)

midazolam accord midazolam (as hydrochloride) 5 mg/ 5 ml solution for injection ampoules

accord healthcare pty ltd - midazolam, quantity: 5 mg - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; sodium hydroxide; water for injections - ? iv as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic;,? iv for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time.,? iv for sedation in intensive care units; intermittent administration or continuous infusion.,? im for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

MIDAZOLAM ACCORD midazolam (as hydrochloride) 50 mg/10 mL solution for injection ampoules Australia - inglés - Department of Health (Therapeutic Goods Administration)

midazolam accord midazolam (as hydrochloride) 50 mg/10 ml solution for injection ampoules

accord healthcare pty ltd - midazolam, quantity: 50 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid; sodium chloride - ? iv as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic;,? iv for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time.,? iv for sedation in intensive care units; intermittent administration or continuous infusion.,? im for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

MIDAZOLAM ACCORD midazolam (as hydrochloride) 5 mg/ 5 mL solution for injection syringe Australia - inglés - Department of Health (Therapeutic Goods Administration)

midazolam accord midazolam (as hydrochloride) 5 mg/ 5 ml solution for injection syringe

accord healthcare pty ltd - midazolam, quantity: 5 mg - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; sodium hydroxide; water for injections - iv as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic; iv for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time. iv for sedation in intensive care units; intermittent administration or continuous infusion. im for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

MIDAZOLAM ACCORD midazolam (as hydrochloride) 50 mg/10 mL solution for injection syringe Australia - inglés - Department of Health (Therapeutic Goods Administration)

midazolam accord midazolam (as hydrochloride) 50 mg/10 ml solution for injection syringe

accord healthcare pty ltd - midazolam, quantity: 50 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid; sodium chloride - iv as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic; iv for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time. iv for sedation in intensive care units; intermittent administration or continuous infusion. im for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

DROPERIDOL PANPHARMA droperidol 5 mg/2 mL solution for injection, ampoule Australia - inglés - Department of Health (Therapeutic Goods Administration)

droperidol panpharma droperidol 5 mg/2 ml solution for injection, ampoule

panpharma australia pty ltd - droperidol, quantity: 2.5 mg/ml - injection, solution - excipient ingredients: mannitol; tartaric acid; sodium hydroxide; nitrogen; water for injections - anaesthesia droperidol panpharma injection is indicated to produce tranquillisation and to reduce the incidence of nausea and vomiting in surgical and diagnostic procedures; for premedication, induction, and as an adjunct in the maintenance of general and regional anaesthesia; in neuroleptanalgesia in which droperidol panpharma injection is given concurrently with a narcotic analgesic, to aid in producing tranquillity and decreasing anxiety and pain.,psychiatry the management of severe agitation, hyperactivity, or aggressiveness in psychotic disorders, including schizophrenic reaction and the manic type of manic depressive illness, or in disturbed states, such as some types of acute brain syndrome and in nonpsychotic acute excitation states.

DROPERIDOL PANPHARMA droperidol 1.25 mg/2.5 mL solution for injection, ampoule Australia - inglés - Department of Health (Therapeutic Goods Administration)

droperidol panpharma droperidol 1.25 mg/2.5 ml solution for injection, ampoule

panpharma australia pty ltd - droperidol, quantity: 0.5 mg/ml - injection, solution - excipient ingredients: mannitol; tartaric acid; sodium hydroxide; nitrogen; water for injections - anaesthesia droperidol panpharma injection is indicated to produce tranquillisation and to reduce the incidence of nausea and vomiting in surgical and diagnostic procedures; for premedication, induction, and as an adjunct in the maintenance of general and regional anaesthesia; in neuroleptanalgesia in which droperidol panpharma injection is given concurrently with a narcotic analgesic, to aid in producing tranquillity and decreasing anxiety and pain.,psychiatry the management of severe agitation, hyperactivity, or aggressiveness in psychotic disorders, including schizophrenic reaction and the manic type of manic depressive illness, or in disturbed states, such as some types of acute brain syndrome and in nonpsychotic acute excitation states.

DROPERIDOL PANPHARMA droperidol 2.5 mg/1 mL solution for injection, ampoule Australia - inglés - Department of Health (Therapeutic Goods Administration)

droperidol panpharma droperidol 2.5 mg/1 ml solution for injection, ampoule

panpharma australia pty ltd - droperidol, quantity: 2.5 mg/ml - injection, solution - excipient ingredients: mannitol; tartaric acid; sodium hydroxide; nitrogen; water for injections - anaesthesia droperidol panpharma injection is indicated to produce tranquillisation and to reduce the incidence of nausea and vomiting in surgical and diagnostic procedures; for premedication, induction, and as an adjunct in the maintenance of general and regional anaesthesia; in neuroleptanalgesia in which droperidol panpharma injection is given concurrently with a narcotic analgesic, to aid in producing tranquillity and decreasing anxiety and pain.,psychiatry the management of severe agitation, hyperactivity, or aggressiveness in psychotic disorders, including schizophrenic reaction and the manic type of manic depressive illness, or in disturbed states, such as some types of acute brain syndrome and in nonpsychotic acute excitation states.